Skip to main content
OpenTrials

Clinical trial condition

Eczema

Explore clinical trials studying Eczema. Study availability and eligibility vary by location and protocol.

352 public trials 55 recruiting studies
Refine in advanced search Browse all conditions

Eczema trial results

Completed

Phase 2b Study of ASLAN004 in Adults With Moderate-to-Severe Atopic Dermatitis

NCT05158023

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • ASLAN Investigative Site Birmingham, Alabama, United States
  • ASLAN Investigative Site Birmingham, Alabama, United States
  • ASLAN Investigative Site Little Rock, Arkansas, United States
  • Tooraj Raoof, MD Encino, California, United States
View all 83 locations
View Trial Details
Completed

Study of an Anti-OX40 Monoclonal Antibody (KHK4083) in Subjects With Moderate to Severe Atopic Dermatitis

NCT03703102

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Kyowa Investigational Site US-19 Huntington Beach, California, United States
  • Kyowa Investigational Site US-17 Irvine, California, United States
  • Kyowa Investigational Site US-09 Los Angeles, California, United States
  • Kyowa Investigational Site US-05 Santa Ana, California, United States
View all 58 locations
View Trial Details
Completed

A Study to Evaluate Safety and Effectiveness of Cendakimab (CC-93538) in Participants With Moderate to Severe Atopic Dermatitis

NCT04800315

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +9 more
Locations
  • Clinical Research Center of Alabama Birmingham, Alabama, United States
  • Local Institution - 119 Birmingham, Alabama, United States
  • Cahaba Dermatology Birmingham, Alabama, United States
  • Local Institution - 114 Birmingham, Alabama, United States
View all 157 locations
View Trial Details
Completed

HPA Axis Study in Adults

NCT01408511

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • PAREXEL Bloemfontein Bloemfontein, South Africa
  • PAREXEL George George, South Africa
  • PAREXEL Port Elizabeth Port Elizabeth, South Africa
View Trial Details
Completed

A Study of Lebrikizumab (LY3650150) on Vaccine Response in Adults With Atopic Dermatitis (ADopt-VA)

NCT04626297

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Clinical Research Center of Alabama- Birmingham Birmingham, Alabama, United States
  • Burke Pharmaceutical Research Hot Springs, Arkansas, United States
  • Arkansas Research Trials North Little Rock, Arkansas, United States
  • Orange County Research Institute Anaheim, California, United States
View all 85 locations
View Trial Details

Related conditions